search

PubMed Search Builder

Topoisomerase II Inhibitors [Pharmacological Action]

Tree Number(s): D059005
MeSH Unique ID: D059005
Entry Terms:
  • 1,2,3-O-acetyl-1,2,3-demethyl-N-(4'-nitrobenzoyl)deacetylthiocolchicine (Supplementary Concept)
  • 1,3,4,5,6,7,8,10-octahydro-14-hydroxy-12-methoxy-11-methyl-4-(3-methyl-1,2,4-oxadiazol-5-yl)-6-thioxo-9,2,5-benzoxanthiaazacyclododecine-10-one (Supplementary Concept)
  • 1,3,4,5,6,7,8,9,10,12-decahydro-16-hydroxy-14-methoxy-13-methyl-4-(3-methyl-1,2,4-oxadiazol-5-yl)-6-thioxo-11,2,5-benzoxathiaazacyclotetradecine-12-one (Supplementary Concept)
  • 1-(3'-hydroxypropyl)-4,6,8-trimethylfuro(2,3-h)quinolin-2(1H)-one (Supplementary Concept)
  • 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxyic acid (Supplementary Concept)
  • 2,3-dihydroindolizino(7,6,5-kl)acridinium chloride (Supplementary Concept)
  • 2-(2'-(dimethylamino)ethyl)-1,2-dihydro-7-ethoxydibenz(de,h)isoquinoline-1,3-dione (Supplementary Concept)
  • 2-(2-dimethylamino)-6-thia-2-azabenzo(def)chrysene-1,3-dione (Supplementary Concept)
  • 2-(3',4'-dihydroxyphenyl)-5,7-dihydroxy-3-(2'',6''-di-O-(3'''-(4-fluorophenylpropanoyl)))galactosyl-4H-chromen-4-one (Supplementary Concept)
  • 2-(4-methoxyphenyl)-5-((4-methylpiperazin-1-yl)-3H-imidazo(4,5-b)pyridin-2-yl)-3H-imidazo(4,5-b)pyridine (Supplementary Concept)
  • 3'-deamino-3'-hydroxydoxorubicin (Supplementary Concept)
  • 3-amino-7-(3-(1-aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-1H-quinazoline-2,4-dione (Supplementary Concept)
  • 3-O-coumaroylbetulinic acid (Supplementary Concept)
  • 4'-O-demethyl-4-(4''-(benzimidazol-2''-yl)anilino)-4-desoxypodophyllotoxin (Supplementary Concept)
  • 4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione (Supplementary Concept)
  • 4-benzoyl-1-(4-methyl-imidazol-5-yl)carbonylthiosemicarbazide (Supplementary Concept)
  • 4-demethoxy-3'-deamino-3'-hydroxydoxorubicin (Supplementary Concept)
  • 4-demethoxy-3'-deamino-4'-deoxy-4'-aminodaunorubicin (Supplementary Concept)
  • 4-methoxybenzo(a)phenazine-11-carboxylic acid (2-(dimethylamino)-1-methylethyl)amide (Supplementary Concept)
  • 4-methyl-7-(tetradecanoyl)-2H-1-benzopyran-2-one (Supplementary Concept)
  • 5,11-dimethyl-5H-indolo(2,3-b)quinoline (Supplementary Concept)
  • 5,8-bis(2-aminoethylamino)-1-azaanthracene-9,10-dione (Supplementary Concept)
  • 5-(2-(5-chloroindol-3-yl)vinyl)pyrazole (Supplementary Concept)
  • 6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one (Supplementary Concept)
  • 7-(3-(1-aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-1H-quinazoline-2,4-dione (Supplementary Concept)
  • 7-(4-(4-tert-butylbenzyloxy)-1H-indazol-3-ylmethylsulfanyl)-4-methylcoumarin (Supplementary Concept)
  • 8-azabatracylin (Supplementary Concept)
  • 8-desaminobatracylin (Supplementary Concept)
  • 9'-fluoro-10'-(4-methyl-1-piperazinyl)-7'-oxospiro(cyclopropane-1,3'(2'H)-(7H)pyrido(1,2,3-de)(1,4)benzoxazine)-6'-carboxylic acid (Supplementary Concept)
  • 9-bromophenazine-4-carboxamide (Supplementary Concept)
  • A 62176 (Supplementary Concept)
  • A 85226 (Supplementary Concept)
  • Aclarubicin (MeSH Term)
  • alatrofloxacin (Supplementary Concept)
  • alpha-lapachone (Supplementary Concept)
  • amifloxacin (Supplementary Concept)
  • antofloxacin (Supplementary Concept)
  • ardisin (Supplementary Concept)
  • asulacrine (Supplementary Concept)
  • azatoxin (Supplementary Concept)
  • balofloxacin (Supplementary Concept)
  • bastadin 14 (Supplementary Concept)
  • BE 10988 (Supplementary Concept)
  • BE 13793C (Supplementary Concept)
  • BE 22179 (Supplementary Concept)
  • besifloxacin (Supplementary Concept)
  • bis(helenalinyl)glutarate (Supplementary Concept)
  • bis(isoalantodiol-B)glutarate (Supplementary Concept)
  • carbobenzoxycoumarin (Supplementary Concept)
  • Carubicin (MeSH Term)
  • chlorobiocic acid (Supplementary Concept)
  • Cinoxacin (MeSH Term)
  • Ciprofloxacin (MeSH Term)
  • CJ 12371 (Supplementary Concept)
  • CJ 12372 (Supplementary Concept)
  • CJ 12373 (Supplementary Concept)
  • clinafloxacin (Supplementary Concept)
  • corylifolin (Supplementary Concept)
  • coumermycin (Supplementary Concept)
  • cyclothialidine (Supplementary Concept)
  • Daunorubicin (MeSH Term)
  • Dexrazoxane (MeSH Term)
  • Doxorubicin (MeSH Term)
  • eleutherin (Supplementary Concept)
  • Enoxacin (MeSH Term)
  • Epirubicin (MeSH Term)
  • etirinotecan pegol (Supplementary Concept)
  • Etoposide (MeSH Term)
  • FD 501 (Supplementary Concept)
  • finafloxacin (Supplementary Concept)
  • Fleroxacin (MeSH Term)
  • flumequine (Supplementary Concept)
  • garenoxacin (Supplementary Concept)
  • Gatifloxacin (MeSH Term)
  • Gemifloxacin (MeSH Term)
  • GL 331 (Supplementary Concept)
  • GR 122222X (Supplementary Concept)
  • grepafloxacin (Supplementary Concept)
  • Idarubicin (MeSH Term)
  • isoaurostatin (Supplementary Concept)
  • kibdelomycin A (Supplementary Concept)
  • leptosin F (Supplementary Concept)
  • Levofloxacin (MeSH Term)
  • lomefloxacin (Supplementary Concept)
  • makaluvamine H (Supplementary Concept)
  • makaluvamine I (Supplementary Concept)
  • makaluvamine N (Supplementary Concept)
  • matadine (Supplementary Concept)
  • merbarone (Supplementary Concept)
  • methyl 3-(4-(bis(2-chloroethyl)amino)phenyl)-2-(2-(4-((N-isopropyl)amidino)phenyl)furan-5-carboxamido)propanoate (Supplementary Concept)
  • Mitoxantrone (MeSH Term)
  • Moxifloxacin (MeSH Term)
  • N,N-bis(3-(5-bromoacridine-4-carboxamido)propyl)methylamine (Supplementary Concept)
  • N,N-bis(3-(5-methylacridine-4-carboxamido)propyl)methylamine (Supplementary Concept)
  • N-(2'-(dimethylamino)ethyl)acridine-4-carboxamide (Supplementary Concept)
  • N-(2-(dimethylamino)ethyl)-2-(4-pyridyl)quinoline-8-carboxamide (Supplementary Concept)
  • N-(2-(dimethylamino)ethyl)-5-methyl-4-acridinecarboxamide (Supplementary Concept)
  • nadifloxacin (Supplementary Concept)
  • Nalidixic Acid (MeSH Term)
  • neocryptolepine (Supplementary Concept)
  • Norfloxacin (MeSH Term)
  • novobiocin 401 (Supplementary Concept)
  • NSC 659687 (Supplementary Concept)
  • Ofloxacin (MeSH Term)
  • Oxolinic Acid (MeSH Term)
  • pazufloxacin (Supplementary Concept)
  • PD 135042 (Supplementary Concept)
  • PD 138312 (Supplementary Concept)
  • PD 160793 (Supplementary Concept)
  • PD 161148 (Supplementary Concept)
  • Pefloxacin (MeSH Term)
  • PF 03376056 (Supplementary Concept)
  • pixantrone (Supplementary Concept)
  • PNU-286607 (Supplementary Concept)
  • prulifloxacin (Supplementary Concept)
  • Ro 47-3359 (Supplementary Concept)
  • rufloxacin (Supplementary Concept)
  • Ruthenium Ben (Supplementary Concept)
  • Ruthenium Sal (Supplementary Concept)
  • sitafloxacin (Supplementary Concept)
  • sobuzoxane (Supplementary Concept)
  • sparfloxacin (Supplementary Concept)
  • SR 103 (Supplementary Concept)
  • SR 107 (Supplementary Concept)
  • temafloxacin (Supplementary Concept)
  • Teniposide (MeSH Term)
  • tridemethyl-N-(4'-nitrobenzoyl)deacetylthiocolchicine (Supplementary Concept)
  • trovafloxacin (Supplementary Concept)
  • UCT 1072M1 (Supplementary Concept)
  • UCT 1072M2 (Supplementary Concept)
  • ulifloxacin (Supplementary Concept)
  • valrubicin (Supplementary Concept)
  • VRT 125853 (Supplementary Concept)
  • WCK 1734 (Supplementary Concept)
  • WRC 213 (Supplementary Concept)

Comments (0)

No login
gif